Seasonale warned by FDA for ads

Share this article:

A television commercial for Barr Pharmaceuticals's Seasonale misleads consumers by excluding risk information to make the birth control pill seem safer, U.S. health regulators warned in a letter.
The commercial suggests use of the oral contraceptive leads to only four menstrual periods a year but fails to mention frequent and sometimes substantial bleeding, the FDA said in the Dec. 29 letter.

Barr's advertisement, which was created by PACE Advertising of Parsippany, N.J., plays down the risk of irregular menstrual bleeding that can be as heavy as a regular period by suggesting it would subside with continued use of the pill, the letter said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.